WeVote

Bill

Bill

SB 1986

Relating to warning labels for opioid prescription drugs.

89th Legislature (2025) Introduced by Sarah Eckhardt and 3 co-sponsors

Texas bill requiring opioid prescription warning labels at pharmacy point-of-sale to inform patients about addiction risks, overdose dangers, and safe medication handling.

Placed on General State Calendar
0
WeVote Research Nonpartisan
Bill Summary · SB 1986

Legislative bill overview

SB 1986 requires Texas pharmacies to apply warning labels to opioid prescription medications that alert patients to addiction risks, overdose dangers, and safe storage/disposal practices. The bill mandates standardized labeling on all opioid prescriptions dispensed in the state, creating a point-of-sale consumer notification requirement.

Why is this important

Opioid misuse remains a significant public health crisis, with Texas experiencing thousands of opioid-related deaths annually. Warning labels at the pharmacy counter reach patients at a critical moment—when they first receive their medication—potentially influencing safe usage behaviors and reducing accidental overdoses or addiction development.

Potential points of contention

  • Label design and standardization: Disagreement over what warnings should appear, their size/prominence, and whether multiple labels create visual clutter that reduces effectiveness rather than improving it
  • Pharmacy compliance costs: Pharmacies may argue implementation costs for new labeling systems, training staff, and sourcing compliant labels represent an unfunded mandate
  • Efficacy questions: Debate over whether warning labels meaningfully change patient behavior compared to physician counseling or whether literacy/language barriers limit effectiveness for vulnerable populations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.